Trial intelligence / Profile preview

EDGE: Alendronate Discontinuation Pilot

NCT02139007Phase 4Completed

Sponsor
University of Alabama at Birmingham
Start
Jun 2014
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alendronate in osteoporosis, sponsored by University of Alabama at Birmingham. Started Jun 2014; status: completed.

02

Drugs

alendronate
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT02139007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02139007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call